Andrei E. Siniavin - Concepedia

Author

Andrei E. Siniavin

Institute of Bioorganic Chemistry ORCID

Also Known As

A. E. Siniavin, A.E. Siniavin, Andrei E. Siniavin, Andrei Siniavin, Andrey E. Siniavin, А. Э. Синявин

Publications

613

Citations

H-Index

Concepts

All Affiliations

Institute of Bioorganic Chemistry Ministry of Health of the Russian Federation Lomonosov Moscow State University Sechenov University Peoples' Friendship University of Russia

About

Andrei E. Siniavin is an author at Institute of Bioorganic Chemistry specializing in immunology, virology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	264
2	Public Health	2	2	39
3	Biochemistry	1	1	14
4	Biomolecular Engineering	1	1	14
5	Cell Biology	1	1	14

Andrei E. Siniavin

Publications

477

Citations

H-Index

Page 1

	Year	Citations
Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants Vladimir А. Gushchin, Inna V. Dolzhikova, Andrei E. Siniavin, Vaccines Rbd DomainImmunologyVaccine HesitancyCovid-19Vaccine Target	2021	118
Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2 Andrei E. Siniavin, Maria A. Streltsova, Maria A. Nikiforova, Cellular and Molecular Life Sciences Signal TransductionViral PathogenesisImmunologyVenomicsVirology	2021	42
Activation of α7 Nicotinic Acetylcholine Receptor Upregulates HLA-DR and Macrophage Receptors: Potential Role in Adaptive Immunity and in Preventing Immunosuppression Andrei E. Siniavin, Maria A. Streltsova, Denis S. Kudryavtsev, Biomolecules	2020	40
Different Neutralization Sensitivity of SARS-CoV-2 Cell-to-Cell and Cell-Free Modes of Infection to Convalescent Sera Natalia Kruglova, Andrei E. Siniavin, Vladimir А. Gushchin, Viruses VaccinationConvalescent SeraReplication-dependent Reporter VectorsPseudoviral AssayViral Pathogenesis	2021	37
In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1 Andrei A. Pochtovyi, Daria D. Kustova, Andrei E. Siniavin, Vaccines Virus EpidemiologyViral DiagnosticsViral PathogenesisImmunologyCovid-19 Epidemiology	2023	28
Phospholipase A <sub>2</sub> from krait <i>Bungarus fasciatus</i> venom induces human cancer cell death in vitro Thien V. Tran, Andrei E. Siniavin, Anh N. Hoang, PeerJ	2019	27
Oligoarginine Peptides, a New Family of Nicotinic Acetylcholine Receptor Inhibitors Elena V. Kryukova, Igor A. Ivanov, Natalia S. Egorova, Molecular Pharmacology	2019	24
HIV-1 Genetic Diversity in Recently Diagnosed Infections in Moscow: Predominance of A <sub>FSU</sub> , Frequent Branching in Clusters, and Circulation of the Iberian Subtype G Variant Khoren Epremyan, Andrei E. Siniavin, Yury V. Zhernov, AIDS Research and Human Retroviruses	2018	19
The Value of Rapid Antigen Tests for Identifying Carriers of Viable SARS-CoV-2 Elena V. Shidlovskaya, Nadezhda A. Kuznetsova, Elizaveta V. Divisenko, Viruses	2021	17
Engineering T-Cell Resistance to HIV-1 Infection via Knock-In of Peptides from the Heptad Repeat 2 Domain of gp41 Alexandra Maslennikova, Natalia Kruglova, Dmitriy Komkov, mBio	2022	17

Page 1